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INTRODUCTION 
Meningiomas are one of the most common extraaxial neoplasms of 
intracranial nature constituting 13-25% of all intracranial neoplasms. Recent 
advances in neuroimaging has increased the incidence of asymptomatic 
meningiomas. Arising from arachnoid cap cells meningiomas are present in 
varied locations and are of diverse histopathological types primarily 
stratified by the WHO classification into three grades with the majority 
being of benign grade. 
Treatment options for meningiomas have varied historically from 
mere observation to surgery to radiation therapy to combined modalities of 
treatment. Most meningiomas being benign and slow growing proper 
planned treatment is possible thus providing higher chances of complete 
extirpation of these tumours.The degree of complete surgical removal 
essentially depends on the location of the tumour and the presence of nearby 
vital neurovascular structures and eloquent brain matter. The success or 
otherwise of the surgical modality of treatment offered rests on the 
completeness of resection as graded by Simpson grading which primarily 
  
 
correlates the degree of extirpation of the meningioma and associated dura 
with the probability of recurrence. 
The varying and heterogenous nature of presentation of the various 
types of meningiomas and the commonality of occurrence has sparked 
efforts to primarily predict the success of surgical outcomes in meningioma 
surgery.In essential because of the benign histological nature of 
meningiomas it is imperative that proper assessment of the risk and benefit 
ratio of surgery for individual patients with meningiomas is done keeping 
with the basic tenet of benefits to far outweigh the risks involved. With this 
aim in mind various stratification systems like the “CLASS” algorithm have 
been developed the validity of which is assessed in this study. 
 
 
 
 
 
 
 
  
 
AIM OF THE STUDY 
 
Aim of the study is,  
1) To analyze the various epidemiological and risk factors associated 
with and influencing surgical outcome in the treatment of 
meningiomas. 
2) To assess the validity of the CLASS algorithm as applied to patients  
diagnosed with meningiomas and subject to surgical treatment and 
comparing the findings and  outcome of this study with other major 
studies in literature utilizing CLASS algorithm for meningiomas. 
 
 
 
 
 
 
 
 
 
  
 
REVIEW OF LITERATURE 
The study of meningiomas which are the most common extracranial 
tumors of intracranial origin makes interesting considerations as the 
presentation and clinical features of meningiomas covers the whole gamut of 
neurosurgical spectrum considering the varied locations where these lesions 
are located making them truly “ubiquitous”” in nature. 
According to epidemiological studies meningiomas form about 33.8% 
of all primary brain and CNS tumours1 and are one of the most commonly 
diagnosed primary brain tumours. This statistical viewpoint has also been 
modified and challenged and tends to include incidentally diagnosed groups 
of meningiomas which account for those kind of tumours that are diagnosed 
during autopsy2 and by incidental neuroimaging.It has also been analyzed 
that a 3-3.9 fold increased incidence of meningiomas3 has been recorded in 
the post Computerized Tomography era. 
Risk factors involved in the pathogenesis of meningiomas have been 
diverse in nature and range from inherited genetic polymorphisms mainly in 
association with NF-2.Other risk factors include environmental factors such 
as ionizing radiation4 and exogenous and endogenous hormones5. Population 
  
 
statistics based on epidemiological studies indicate about 20% incidence in 
males and 38% in females3.The mean ratio of occurrence varies from 1:1.4 
to 2.66 .This observation also has an inherent ethno geographic connotation 
in that the overall incidence and sexual predilection is less common in Asian 
racial groups7 
The consensus with regard to age related incidence of the intracranial 
meningiomas is that there is a marked positive correlation of increased 
occurrence1 with increasing age. The peak incidence being in the mean age 
of 56.4 in males and 55.9 in females. The highest percentage of tumour 
occurrence is in the age group of 40-59 (37%) and 60-79 (38%) respectively. 
Pathophysiologic analysis with respect to the site of occurrence 
reveals no specific predilection with respect to side, the right side involved 
in 44% of lesions and the left in 43% of lesions.Histopathologically most of 
these (92%) fall into the benign category with 8% showing atypical or 
malignant features8.Based on histologic features the meningothelial type is 
the most common about 63% of tumors, the second most common is the 
transitional type (19%) closely followed by fibrous type (13%) and the 
psammomatous type (2%). Based on the microscopic findings of degree of 
mitoses and cellular changes of increased cellularity,small cell formation, 
  
 
prominent nucleoli, sheet like and areas of spontaneous growth, 
meningiomas can be divided into atypical (4 or more mitoses/10 HPF) types 
like chordoid and clear cell and anaplastic (20/10 HPF),rhabdoid and 
papillary types the latter being the more aggressive associated with grave 
implications on morbidity and mortality of affected kindreds9. 
With regard to the site of occurrence of meningiomas parasagittal and 
falcine (25%),convexity lesions (19%),sphenoid ridge 17%, followed  
by suprasellar 9%, posterior fossa 8%, olfactory groove 8%, middle 
fossa/Meckel’s cave 4%, tentorial 3%, peri-torcular 3%, lateral ventricle 1–
2%, foramen magnum 1–2%, and orbit/optic nerve sheath 1–2%. 
 Among the parasagittal meningiomas,49% are located over the 
anterior one third of the falx, with29% in the middle third, and 22% along 
the posterior third.Medial sphenoid ridge meningiomas were more common 
than middle or lateral sphenoid ridge meningiomas.  
Multiple meningiomas or meningiomatosis is encountered in 2.5% of 
meningiomas The incidence of ectopic location is 0.4% with the majority 
(73%) occurring inside the orbit, paranasal sinuses, eyelids, parotid gland, 
temporalis muscle, temporal bone, and zygoma. Distant sites have also been 
reported, such as the lungs, mediastinum, and the adrenal glands10. 
  
 
The histological nature also has some correlation with the site of 
occurrence in that lesions located in the midline of the skull base are 
meningothelial in nature as demonstrated by Lee et al11.  
The malignant and atypical type of meningiomas are located primarily 
in the supratentorial compartment (73-75%)12 primarily over the cerebral 
convexities with the ratio of calvarial to skull base lesions being 2.3: 113. 
Environmental causes of risk factors associated with meningiomas 
include ionizing radiation with a six to ten fold increased risk. Therapies 
used for treatment of Tinea Capitis in children and for intracranial tumours 
and investigative modalities like dental radiographs and CT scans have also 
been traditionally associated with increase in odds ratio14 of occurrence of 
meningiomas. 
The increased and widespread use of cellular mobile phones has 
prompted intensive debate regarding the risks of increased incidence related 
to cell phone use related to occurrence of meningiomas. The primary 
pathophysiologic factor implicated was the microwaves with most studies 
indicating no correlation16 though some indication related to increased 
occurrence of gliomas being demonstrated in some studies15. 
  
 
 The tumorigenesis of meningiomas in female patients has been a 
subject matter of interest in that increased risk of occurrence with positive 
correlation has been shown with hormonal replacement therapy especially 
with long acting therapies like dermal implants and hormonal IUDs17. 
OCP use though has not shown any characteristics of increased 
occurrence. Therapeutic intervention in the form of anti-hormonal therapy 
has not been proven to be efficacious in the overall treatment of 
meningiomas18. 
Trauma has been purported to play an important role in the evolution 
of meningiomas since the time of Cushing and Eisenhardt, more in the male 
population with a reported lag period of about 10 -19 years19. But recent 
studies have negated the possibility as is shown by the Mayo Clinic analysis 
of meningiomas showing no special predilection due to trauma20. 
The implication of viruses in the etiopathogenesis of meningiomas has 
been inconclusive21 with recent investigative modalities like PCR and IHC 
showing no relation to SV40 Tag,JC virus or BK virus infection.The 
detection of viral DNA, RNA or antigens has  been attributed to either latent 
infection or contamination22. 
 
  
 
The natural history of meningiomas reveals the benign and slow 
growing nature of these tumours. It has been shown that about 3% of adults 
above 60 harbour asymptomatic meningiomas.23 
Volumetric analysis of meningiomas which are asymptomatic have 
shown a growth rate of about 4mm/year.Studies have revealed that serial 
imaging modalities show that the annual growth rate of asymptomatic 
meningiomas of less than 1cm3 m/year have been recorded in 66% of such 
patients and the tumour doubling time was about 21.6 years.24However the 
exact epidemiology has been difficult to quantify because of the variation in 
clinicoradiological assessment of exact tumour growth. 
The general consensus is that tumours detected in younger age group 
of patients possess an inherent faster and accelerated tumour growth 
compared to similar lesions in the elderly especially patients over the age of 
60. 
Tumoural biology of meningiomas also has a heavy bearing on the 
progression of these lesions. Characteristics like excessive calcification as 
evidenced by hypointensity in MRI imaging studies, the initial size and 
volume of the tumour at time of presentation and the site of location of these 
  
 
lesions play an important and significant role in the assessment of natural 
growth pattern of meningiomas.25 
With regard to the location of meningiomas the lesions that occupy 
the skull base especially the region around the cavernous sinus, clinoidal 
processes and petroclival region have been shown to demonstrate slow or 
indolent type of growth despite alarming nature of presentation in imaging 
studies. Such tumours because of their inherent lack of progression and 
growth also demonstrate only limited clinical and neurological deterioration 
mostly spread over a long period of time.26 The counter argument in the 
treatment of skull base lesions is that their infratentorial location coupled 
with the irregularity in shape makes it less amenable to exact volumetric 
assessment and hence patients with small and medium sized lesions with a 
higher propensity of growth should be subjected to early surgical treatment 
depending on the individual assessment of the risk benefit ratio pertinent to 
each patient.26 
The progression of tumours also depends on the histologic grade of 
meningiomas based on the WHO classification with the tumour doubling 
time ranging from 415+ days for grade I tumours to 205+ days for grade III 
tumours with definite indicators of significant difference between grade I 
  
 
and grade II/III tumours27. The tumour doubling time has also been linked to 
the variation in cellular proliferative and divisional capabilities of individual 
cells as evaluated and stratified by the mitotic index,labelling indices like 
MIB/Ki-67/BUdR.28 
Imaging modalities play an important role in the 
evaluation,assessment,stratification,risk analysis, surgical planning,treatment 
protocol, risk-benefit ratio appraisal and recurrence probability of 
meningiomas.The use of CT characteristics and MRI evaluation form the 
basis of localization of the various types of meningiomas.The classical 
finding in MRI is the enhancement on T1W contrast imaging and the 
hyperintensity in T2W imaging with variations depending on the histologic 
characteristics.Adjunctive treatment protocols like MRS, Octreotide 
scintigraphy, PET scanning, SPECT scanning.29 
The role of preoperative angiography is paramount with the features 
of the blush and the marginal sunburst appearances providing more than 
adequate detail regarding the source of the blood supply thus helping in 
prediction of adequacy of surgery and also to assess the need for 
preoperative embolization and also help in devascularisation and efficient 
extirpation of meningiomas.30 
  
 
Depending on the localization of the lesions the symptomatology of 
tumours differs with headache and seizures forming the bulk of presentation 
characteristics.The varied spectrum of presentation with regard to the 
neurological deficits mirrors the functional organisation of the nervous 
system. The neurological deficits are also influenced by the degree of 
encasement and displacement of vital vascular and neurological structures. 
The benign and slow growing nature of majority of meningiomas 
entails various management options which include observation, surgical 
options, radiation both as an adjunct and as primary therapy. The measure of 
success of outcome is primarily measured by the degree of clinical 
improvement as assessed by various scales and scores such as Glasgow 
outcome scoring and the Karnofsky Performance Scale (KPS). 
The type of meningioma and location of the lesion and the degree of 
neurological involvement and patient characteristics such as age, presence of 
comorbidities and the location and grade of possibility of resection as is 
evaluated by the various investigative modalities provides an adequate 
roadmap for the type of management that is contemplated. 
Observation with periodic followup and neuroradiological imaging is 
one of the modalities of treatment preferred primarily in patients with certain 
  
 
type of skull base meningiomas which are asymptomatic or present with 
minimal symptoms, patients who present with incidental tumours with very 
little oedema, and those group of patients who chose non-surgical modes of 
therapy but in all these conditions the primary emphasis is on the willingness 
and essentiality of both clinical and radiological followup.The location of 
tumours and the degree of extirpation and resection that is adequately 
possible as judged by clinicoradiological correlation also dictates advocacy 
of observation taking into account the risk benefit ratio of surgical 
methodologies.31 
The evolution of surgical management of meningiomas entails 
interesting study in that it mirrors the development of neurosurgery.The 
earliest recorded surgical extirpation was performed by Laurence Heister in 
1743 in Helmstad, Germany.The surgical removal of dural based tumours 
was primarily described by Italian neurosurgeon Andrea Berlingheiri in 
1813.The first successful removal of intracranial meningioma was done by 
Zanobi Pecchioli in Siena in 183532. Sir William Macewen described the 
index successful removal of an olfactory groove meningioma in 184933 and 
the first success in the United States was by William Keen in 1887.  
  
 
The thorough documentation and description of the various facets of 
meningiomas was first done by Herbert Olivecrona but the most exhaustive 
and all-encompassing work on meningiomas was done by none other than 
Harvey Cushing who along with Louise Eisenhardt produced the 
voluminous treatise on meningiomas and the associated features and surgical 
management with special emphasis on outcome and end results.34 
The advancement in techniques and instrumentation technology has 
influenced both the type of surgical treatment and refined the method of 
resection being done and has helped definitely to reduce the degree of 
recurrence thus helping in both improving the overall surgical outcome and 
improving the quality of life of patients afflicted with this pathology. 
About 92% of meningiomas are treated by surgical methodologies and 
this is dictated by the area of location of the lesion. The intended goals of 
therapy are to primarily resect the tumour along with the involved dura and 
adjoining bone.This is to a large extent influenced by the degree of 
hyperostosis and bony involvement that is inherently present during 
presentation.35 
The second goal of surgery is to reverse or aim to ameliorate the 
neurological deficits and strive to improve the morbidity of the patient. 
  
 
Other anciliary surgical goals in difficult to access tumoursa is the aim 
of obtaining samples for tissue diagnosis and debulking of the lesion in order 
to make it more amenable for radiosurgery. 
The improvement in radiotherapeutic modalities and the advent of 
better delivery methods for radiosurgery has influenced the extent of 
radicality and has tilted the scale towards lower risk to benefit ratios with the 
remnant tumour mass being dealt with radiosurgical alternatives. 
The success of surgical therapetics has traditionally been measured by 
the Simpson grading.The basic tenets of surgery36 in meningiomas are : 
1) Optimal positioning, incision and exposure 
2) Early tumour devascularization 
3) Intratumoural debulking and extracapsular dissection 
4) Early localization and protection of neurovascular structures 
5) Adequate removal of bone and dura. 
The adequacy of resection was propounded by the five stage 
classification system as devised by Simpson in 195737.It essentially helped 
to predict the degree of expected recurrence with grade I resections having a 
10% recurrence with a progressive increase in recurrence in the higher 
grades of resection. 
  
 
The microsurgical perspective was introduced into the Simpson 
system by Kobayashi et al in 1992 with the microscopic resection being 
incorporated into the Simpson classification. 
 
GRADE        DESCRIPTION 
0 Macroscopically complete tumor removal with excision of 
the tumors dural attachment and any abnormal bone with 
margin of 2cm. 
I Macroscopically complete tumor removal with excision of 
the tumors dural attachment and any abnormal bone 
II Macroscopically complete tumor removal with 
coagulation of its dural attachment 
III Macroscopically complete removal of the intradural tumor 
without resection or coagulation of its dural attachment or 
extradural extensions 
IV Subtotal removal of the tumor 
V Simple decompresssion of the tumor 
 
 
 
 
 
 
 
  
 
Modified Shinshu Grade /Okudera Kobayashi Grade 
 
 
The outcome of surgery in meningioma treatment is evaluated on the 
basis of various parameters these being primarily divided into 
Patient related 
Procedure related 
Pathology related 
Surgeon related 
 
  
 
The interrelationship of these various factors determines the 
morbidity, mortality and the ultimate quality of life of patients with 
meningiomas as measured by KPS and GOS. 
Comorbidity status of the individual, age ,location and size of the 
tumour,and the presence or absence of neurological deficit are the most 
important of the procedure related parameters that influence surgical 
outcome. 
The QOL (Quality of life ) measurement is also of paramount 
importance as irrespective of surgical procedure related success the efficacy 
of the outcome depends on the functional outcome of the patient. 
Complications inherent to the pathology and the operative intervention are 
primarily divided into surgical and medical complications. 
The important surgical complications are infection hemorrhage, CSF 
leakage, pseudomeningoceles and wound related problems. The medical 
complications essentially fall into deep vein thrombosis, seizures and 
pulmonary embolism. 
The rethink in the modality of treatment suitable for each patient has 
been necessitated by the improvement in the efficaciousness of both 
radiation therapy and radio surgery protocols. 
  
 
Traditionally the extent of surgical resection as stratified by the 
Simpson grade of resection has been used to predict the risk of recurrence 
with lower grades correlated with decreased probability of recurrence. 
Additional factors of importance include the WHO grade of tumour with 
higher grades like atypical and anaplastic kindreds necessitating gross total 
resection to reduce the incidence of recurrence as this is associated with poor 
prognosis and decrement in overall survival and morbidity patterns. 
Proliferative markers such as MiB-1,CDKN 2A deletion have been 
associated with marked and intense increase in the doubling time and 
regrowth potential after surgical extirpation thus influencing the morbidity 
and progression profile of these lesions. 
The site of occurence and location of the meningioma also determines 
the ease of approach and the potential for complete resection. Based on the 
location olfactory groove and planum sphenoidale meningiomas have shown 
a 4.9% recurrence over a 5 year period with gross total resection of 92%.38 
Tuberculum sellae meningiomas pose difficulties in resection as they 
are  in close proximity to vital neural and vascular structures especially the 
optic nerve with a recurrence rate of 2.8% in a mean follow up of 3.8 years 
  
 
but with a visual deterioration of 17-20%.Hence the need for close follow up 
as there exists a need for radiosurgery or repeat surgery.39 
Optic nerve sheath meningiomas present an important category in the 
sense that the degree of morbidity dictates the treatment approach and 
Dutton et al have reviewed these lesions and report a 30% morbidity with a 
25% recurrence and only a 5% improvement in visual symptoms with 
surgery specifically indicated only to prevent intracranial extension or 
spread of lesions.40 
Convexity meningiomas in view of their potential to be amenable to 
total extirpation show only a 1.8%  recurrence with very low morbidity and 
mortality profiles.41 
Parasagittal meningiomas because of their unique relationship to the 
SSS have been associated with a recurrence rate of 4% if SSS is not 
involved but about 13.9% if the SSS is encompassed.Fractionated 
radiotherapy is now found to be more useful in these lesions.42 
Sphenoidal ridge meningiomas show a recurrence rate of 9-18.9% 
with the medial sphenoidal types showing a higher rate because of the 
potential involvement of the cavernoussinus and the adjoining neurovascular 
structures.43 
  
 
Clinoidal meningiomas are limited by the degree of proximity to the 
Internal Carotid vessel and micro neurosurgery has proved effective in 
decreasing the recurrence potential by improving the extent of extirpation.44 
Cavernous sinus meningiomas are associated with both an intra and 
extracavernous involvement and recurrence rates of about 13% have been 
reported but with the high incidence of morbidity and neurovascular 
compromise multimodality treatment with the addition of radiotherapy are 
reported to yield better results.45 
Petro-clival meningiomas form one of the most complex groups of 
lesions as they are inherently difficult to completely resect the completeness 
of which depends on the intactness of the arachnoid plane,consistency of the 
lesion and the proximity of vital elements with recurrence rates as high as 
25%.This has prompted the subtotal resection with adjuvant radiotherapy is 
the treatment of choice in these meningiomas. Stereotactic radiotherapy with 
fractionation or multisession in the case of larger tumours is also effective 
with adequate debulking in 92-97% of patients.46 
In cerebellopontine angle meningiomas the primacy is preservation of 
the function of the VII and VIII nerve with better results possible in lesions 
  
 
located posterior and superior to the IAC compared to intrameatal and 
premeatal locales.47 
Foramen magnum and jugular foramen meningiomas are in proximity 
to the brainstem and the lower cranial nerves precluding complete resection 
without compromise in function.48 
Cerebellar convexity meningiomas have a recurrence rate of 14% over 
19 months the incomplete resection due to the presence of the Torcula 
heterophili the management of which has lead to poor outcomes.49 
Tentorial meningiomas present in a wide spectrum of varieties with 
complete resection rates of 77-91% with recurrence rates of 8.1% (Grade I 
resection only ) with a morbidity rate of 19.8% and mortality rate of 2.5% 
with the falcotentorial and the peritorcular being the most difficult and need 
extensive venous sinus reconstruction when the recurence rates 
demonstrated are 16-17%,the preservation techniques are associated with a 
25% recurrence.50 
Intraventricular meningiomas are associated with hydrocephalus and 
attendant increased morbidity the surgical resection of these are associated 
with a recurrence of about 8.3% when gross total resection rates are pegged 
at 87.5%.51 
  
 
With this background of information the "CLASS" algorithm was 
proposed by Lee et al, the purpose of which was to analyze the risk benefit 
ratio of the surgical alternatives provided to patients with meningiomas and 
the study of the impact of the various preoperative risk factors on the degree 
of functional outcome after surgery. 
 
The stratification of patients is based on the factors of  
    1)  Comorbidity 
 It is assessed the use of the ASA scale with reference to the 
ability or otherwise of patients to withstand surgical procedures and tolerate 
anaesthetic medications. The scores assigned are 0 for grade I, -1 for ASA II 
and -2 for ASA III.ASA IV and ASA V are not included as they are not 
considered desirable candidates for surgery. 
2) Location: 
  Tumor location was classified as 
 “Low-risk” locations included convexity and lateral skull base 
(lateral and middle sphenoid wing, posterior petrous) and were given a 
score of 0. Olfactory groove, planum 
  
 
sphenoidale, tentorial (lateral/paramedian), parasagittal, 
intraventricular,cerebellopontine angle, falcine,posterior/lateral foramen 
magnum as well as para-sigmoid and para-transverse 
sinus locations constituted the “moderate risk” group and were assigned a 
score of -1. The “high-risk” locations included clinoidal, cavernous sinus, 
tuberculum sellae, tentorial (medial/incisural), ventral petrous, petroclival 
and anterior/anterolateral foramen magnum, for which a score of -2 was 
given. 
3) Age: 
A score of 0 was assigned for patients who are 60 years of age or 
younger, -1 for 61–70 years and -2 for 71years or older. 
4) Size: 
A score of 0 was given if the maximum tumor size was 2 cm or less, 
+1 for between 2.1 and 4 cm, and +2 for tumors larger than 4.1 cm. 
5) Signs and symptoms: 
A score of 0 was assigned for incidentaltumors and +1 for mild 
symptoms or irreversible neurologic deficits. A score of +2 was assigned 
for severe symptoms or reversible 
neurologic deficits. 
  
 
 
 
 
 
 The stratification of outcome is done using the GOS and the attendant 
neurological, post-operative and medical complications are factored in 
the compartmentalization of the patients undergoing surgical treatment of 
meningiomas and the risk benefit ratio assessment thereof. 
 
 
 
  
 
MATERIALS AND METHODS 
 The analysis was done after proper approval from the IRB/IEC of 
Government Rajaji Hospital, Madurai on patients who were admitted in the 
Department of Neurosurgery, Government Rajaji Hospital during the period 
2009-2013 and were diagnosed as having meningiomas on the basis of 
clinical and radiological features. 
 The variables studied included the age, sex and presenting symptoms 
of the patient with stratification of the patients with regard to their 
comorbidities and pre-existing medical and chronic disorders and the clinical 
profile and placed as per the ASA(American Society of Anaesthesiologists) 
grading from I to IV. 
 The radiological picture was recorded and the parameters studied 
were the cross sectional size of the lesion in its maximum extent as reported 
by the radiologist using standard protocol. Other parameters studied were the 
anatomical location of the lesion with respect to the normal anatomical 
disposition of the tumour and the degree of proximity to the vital neural and 
the vascular entities present in that area and the degree of secondary effects 
  
 
caused by the lesion to the internal milieu of the brain and intracranial 
compartments. 
 The inclusion criteria for the patients were categorized as those who 
were offered the surgical alternative and were willing for surgery as well as 
amenable and accessible to regular follow up. 
 The patients who underwent surgery were studied with regard to the 
degree of extirpation that was done based on the Simpson grading of 
meningioma resection. The postoperative course was monitored and the 
patients were assessed at the end of the first week of convalescence and after 
six weeks following surgery based on the GOS(Glasgow Outcome Scale) 
between 1-5 (worst- best). 
 All these parameters were included in the risk stratification and with 
special emphasis with respect to comorbidities, location, age, size and signs 
and symptoms and these were used for calculation of the CLASS scoring 
and grouping of patients based on this algorithm. 
 Based on the outcome as assessed by the GOS and the presence of 
complications (neurological and medical) the outcome evaluation of surgery 
was done for the three groups of patients under the various CLASS groups 
  
 
and the results were analyzed with regard to the success and otherwise of the 
surgery for the various types of meningiomas and the observations are 
presented. 
The information collected regarding all the selected cases were 
recorded in a Master Chart. Data analysis was done with the help of 
computer using Epidemiological Information Package (EPI 2002). Using 
this software, range, frequencies, percentages, means, standard deviations, 
Students‘t’ test, Chi square testand ‘p’ values were calculated. A 'p' value 
less than 0.05 is taken to denote significant relationship. 
 
 
 
 
 
 
 
  
 
RESULTS 
 
The study encompasses the analysis of the evaluation done of about forty 
six patients who underwent surgery for meningiomas during the period 2009 
to 2013.The patients were stratified on the basis of the CLASS algorithm 
and the outcome parameters were analysed. 
The demographic epidemiology of the forty six patients is as follows. 
The grouping of patient with respect to the age wise break up is 
 
 
 
 
 
 
 
 
Age Range  No. of patients Percentage 
< 29 6 13 
30-39 10 22 
40-49 18 39 
50-59 8 17 
> 60 4 9 
  
 
 
 
The sex based incidence was as follows (M: F) 
Sex Number Percentage 
Male 11 24 
Female 35 76 
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With regard to the symptomatology of presentation the findings were 
as follows 
 Headache and vomiting  - 38 
 Headache alone   - 2 
 Seizures    - 9 
 Hemiparesis/Deficits  - 3 
 Behavioural disturbances  - 2 
 Diminution of vision  - 7 
  Papilledema   - 3 
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The location of the lesion and the radiological correlate were 
found to be 
 Left sided lesions - 21 
 Right sided lesions - 18 
 Midline structures - 7 
Side of lesion Number Percentage 
Left Sided Lesions 21 46 
Right sided lesions 18 39 
Midline lesions 7 15 
 
 
SIDE OF LESION
LEFT
RIGHT
MIDLINE
  
 
The anatomical location of the meningiomas as radiologically diagnosed and 
the findings were 
 
Location of the lesion Number of 
patients 
Percentage 
Convexity 14 30 
Parasagittal 7 15 
Tentorial 6 13.5 
Sphenoid wing 6 13.5 
Falcine 3 7 
Olfactory groove/Basifrontal 3 7 
Suprasellar 2 4 
Cerebellopontine angle 2 4 
Petroclival 1 2 
Clinoidal 1 2 
Intraventricular 1 2 
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The other parameter that was diagnosed radiologically was with 
respect to the size of the lesion 
Size greater than 4cm  - 19 
Size less than 4cm  - 27 
 
 
 
 
 
 
 
SIZE >4cm
SIZE <4cm
  
 
The preoperative functional status of the patient was analysed 
based on the ASA scale and the stratification was 
 
ASA stage No. of patients Percentage 
I 1 2 
II 27 59 
III 18 39 
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ASA II 2 59 39
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The grade of resection according to Simpson grading was also 
stratified and the results were  
 GRADE 1 GRADE 2 GRADE 3 GRADE 4 
GROUP I 12 13 2 0 
GROUP II 6 6 2 1 
GROUP III 1 2 1 0 
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Based on the above findings with regard to the comorbidity, 
location,age, size and symptoms and signs of the various kinds of 
meningiomas in the sample evaluated the CLASS scoring was performed 
and the groups were assigned  and the following findings were noted. 
 
CLASS 
SCORING 
 
NO.OF 
PATIENTS 
 
PERCENTA
GE 
CLASS I 27 59 
CLASS II 15 32 
CLASS III 4 9 
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All patients were subject to surgical treatment and the results of the 
surgery was measured by the parameters of the Glasgow Outcome Scoring  
at the end of the period of 6 weeks post operatively. The overall GOS 
distribution was as follows 
 
GOS 1 GOS 2 GOS 3 GOS 4 GOS 5 
4(9%) 3(7%) 2(4%) 35 (76%) 2 (4%) 
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The scoring of the patients was done with GOS less than or equal to 3 
taken as poor outcome and GOS more than 3 taken as representative of good 
outcome. 
CLASS GROUP TOTAL POOR 
OUTCOME 
PERCENTAGE 
I 27 4 15 
II 15 3 20 
III 4 2 50 
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The outcome was also assessed on the basis of the postoperative 
neurological and medical complications that were also analyzed. 
 
TOTAL SURGERIES COMPLICATIONS NO COMPLICATIONS 
46 12(26%) 34(74%) 
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The grouping of the complications observed with respect to the 
stratification by the CLASS algorithm is observed as follows 
CLASS GROUPING COMPLICATIONS PERCENTAGE 
GROUP I 5/27 18 
GROUP II 5/15 33 
GROUP III 2/4 50 
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 The distribution of the type of complications included wound related 
predominantly pseudomeningocele and neurological complications such as 
visual deterioration,hemiparesis,aphasia and behavioral disturbances. 
 The study also included medical complications the most important of 
which was deep vein thrombosis leading on to pulmonary embolism and the 
overall mortality was 3/46 (2 of which were due to associated medical 
complications). 
     
 
 
 
 
 
 
 
 
  
 
DISCUSSION 
 The study encompasses the results of the analysis of 46 patients who 
underwent surgical treatment for meningiomas in the Department of 
Neurosurgery at Government Rajaji Hospital Madurai. 
 The epidemiological analysis revealed that the incidence of 
meningiomas in terms of occurrence was more common in the age group of 
40-49 with 39% of patients presenting in this age group closely followed by 
the age group of 30-39 with 22% compared to the occurrence of these 
tumours in the age group of 55.9-56.4 years as reported by Das et al. and 
compared to the Western population incidence of 55-64 as is revealed by the 
CBTRUS study with an incremental incidence with increasing age.1 
 The overall ratio of sexual preponderance of meningiomas heavily 
tilts towards the female sex with three times more likely incidence and an 
odds ratio of 10.02 indicating ten times the odds of developing eningiomas. 
Male : Female 24:76 1:3 OR -10.02 
 
  
 
 This is in comparison to the male to female ratio of 1:1.4 to 2.6 as 
reported by Alesssandro52 et al and Rohringer5 et al. 
 With regard to the primary symptomatology of presentation the study 
indicates that the most common symptom is headache and vomiting both of 
which are nonspecific in the sense that no localization could be attributed to 
the headache as was evidenced in 40 of 46 patients about 86.9% of the total 
sampled. 
 The  side of lesion as was exemplified in the study was of the 
distribution of a slightly predominant left sided occurrence of 46% 
compared to 39% which were right sided and 15% midline location. 
 The location of the meningioma was of the order that convexity 
meningiomas were the most common accounting for about 30% of the 
lesions with parasagittal and falcine meningiomas making up about 22% of 
the lesions and this is in correlation to the results reported by Christiansen53 
et al and Kloeboe54 et al 
 
 
  
 
Location of the lesion Observed Kloebe et al 
Convexity 30 19 
Parasagittal/falcine 22 25 
Tentorial 13.5 3 
Sphenoidal 15.5 17 
Olfactory groove/Basifrontal 7 8 
Suprasellar 4 9 
             Posterior fossa 6 8 
Intraventricular 2 2 
 
 The observed ‘p’ value was about 0.4 by the t test. 
 With regard to the size of the lesions the findings of the study were of 
the order that 59% of lesions measuring less than 4cm and 41% of lesions 
were greater than 4cm with no significant odds ratio of occurrence. 
 The stratification of patients according to the CLASS algorithm 
revealed that 59% of patients were placed in group I, 32% of patients in 
  
 
Group II and 9% of patients in Group III. This was evaluated in comparison 
to the study by Lee et al. 
CLASS scoring Observed Lee et al.  
Chi square test 
p value= 
0.0002 
 
 
GROUP I 59 36.3 
GROUP II 32 51.4 
GROUP III 9 12.3 
 
 The preoperative morbidity status of the patients analyzed in the study 
was of the finding of 59% of patients placed in the ASA II category and 39% 
of patients in the ASA III category as compared to the 42.6-46% in the ASA 
II category as observed by Lee et al. 
        CLASS group/ASA  
STUDY 
CLASS GROUP I 
ASA II 
CLASS GROUP II 
ASA II 
T TEST 
Observed 55 53  
Lee et al. 42 47.5 p=.04 
  
 
The analysis of grade of resection with respect to the CLASS 
algorithm grouping was elucidated as 44% of group I patients undergoing 
grade 1 resection and 40% of group II and 25% of group III undergoing 
grade 1 resection. 
The outcome parameters of the surgical methodology adopted with 
reference to the CLASS stratification was then analyzed in reference to the 
Glasgow Outcome Scoring and compared with the results obtained by Lee et 
al. 
GOS Scoring Observed Lee et al  
Student’s ‘t’ test 
p value=0.5 
GOS 4-5 80 95.6 
GOS 1-3 20 4.4 
 
The outcome of surgical intervention based on the ‘CLASS’ scoring 
with respect to the poor outcome as measured by the GOS score of 1-3 was 
observed to be about 15% in Group I and 20% in Group II and about 50% in 
Group III and the statistical analysis correlated with Lee et al. (p value-.04) 
  
 
The calculated odds ratio comparison of Group III to Group I was 5.6 
and Group III to Group II was 1.4 
CLASS Group Observed  Lee et al  
Student’s ‘t’ test   
p value=0.04 
I 15 1.8 
II 20 3.9 
III 50 16.2 
 
Odds ratio of having unfavourable outcome according to the CLASS 
score was compared and the analysis is 
CLASS SCORE Odds ratio-observed Odds ratio-Lee et al 
Group III vs.Group I 5.6 10.36 
Group II vs. Group I 1.4 2.17 
 
 
  
 
 The post operative complications observed in the study with respect to 
the grouping according to the CLASS algorithm analysis according to the 
odds ratio was calculated as 4.55 when Group III and Group I was compared 
and 2.03 when Group II and Group I were compared indicative of a 
prominent and higher probability of occurrence of complications. 
COMPLICATIONS Observed 
odds ratio 
Lee et al . 
Odds ratio 
Group III vs. Group I 4.55 4.06 
Group II vs.Group I 2.03 2.33 
 
CLASS 
GROUPING 
OBSERVED -
Complications 
Lee et al – 
Complications 
GROUP I 
18 
7.3 
GROUP II 
33 
15.6 
GROUP III 
50 
24.3 
Student’s ‘t’ test –p value = .02 
    
  
 
CONCLUSION 
The overall results and conclusions from the study corroborate the 
following findings were on the basis of the results of the observations on the 
forty six patients in the study. 
 The epidemiological conclusions were that the incidence of 
meningiomas is highest in the fourth decade with a marked preponderance of 
lesions in females.  
The primary symptomatology is headache of a non-localizing variety 
accompanied by vomiting. Most of these symptoms were mild to moderate 
in intensity and severity. 
 With regard to the imaging findings the location of the lesion was 
more in the convexities of the cerebral hemispheres followed by the 
parasagittal/falcine varieties and tentorial  and sphenoid wing varieties with 
no specific predilection for side and midline located lesions formed a third 
of these varieties. 
 “CLASS” algorithm forms a viable alternative for preoperative 
standardization and stratification of meningiomas and the validity of the 
  
 
algorithm is very well demonstrated by this study as is evidenced by the 
higher correlation of complications and poor outcome in the Group III 
patients. 
 The “CLASS” algorithm thus helps in effective risk factor analysis 
and in helping to predict the risk benefit ratio in patients with meningiomas 
and in eventual identification of those subjects who would benefit the most 
in relation to the preoperative characteristics and the patient associated 
morbidities because of the ease in applicability and utility as is evidenced by 
the comparative results in this study. 
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Intraventricular Meningiomas-CT Scan 
 
     
 
Intraventricular meningioma-MRI T1w (left)/ T1W contrast  
(right) 
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Clinoidal meningiomas-MRI FLAIR 
 
    
 
Clinoidal Meningioma-Coronal(left)/Sagittal (right) 
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STUDY PROFORMA AND QUESTIONNAIRE 
 
Name : 
     
Age/Sex :      
 
MRD No. :  
 
DOA/DOS/DOD : 
 
Complaints : 
 
Comorbidities : 
 
Location of lesion : 
 
Size of Lesion (MRI/CT) :  
 
ASA status : 
  
Surgical Details 
  
 
Intraoperative Findings   : 
Simpson Grade of Resection  : 
Postoperative Course   : 
Histpathological grade (WHO grading) : 
Other factors     : 
Glasgow Outcome Score   : 
CLASS Score 
 COMORBIDITY   : 
 LOCATION   : 
 AGE     : 
 SIZE     : 
 SIGNS/SYMPTOMS    
 
 
 
 
  
 
 
  
 
 
 
MASTER CHART-CLASS Algorithm 
 
 
1 MUTHURAKKU 55/F 84307 22/10/09 LT.TEMPORAL 4X3 Headache/vomiting III -1 GRADE 1 1 Improved 4
2 RAJATHI 55/F 88713 26/10/09 LT.TEMPOROPARIETAL 4X4 Headache/vomiting III 0 GRADE 1 1 Improved 4
3 RAVICHANDRAN 42/M 95602 16/11/09 LT.SPHENOID WING 4X4 Headache/giddiness II 1 GRADE 2 1 Improved 4
4 GORIMA 40/F 07562 03/02/11 RT.FRONTAL CONVEXITY 5X5 Headache/Seizures II 2 GRADE 1 1 Improved 4
5 THANGAM 23/F 11721 21/02/11 RT.TENTORIAL 3X3 Headache/papilledema II 2 GRADE 2 1 Improved 4
6 PETCHIAMMAL 36/F 13749 02/03/11 RT.PARIETAL 4X5 Headache/weakness II 3 GRADE 1 2 Improved 4
7 BOSE 62/M 17888 21/03/11 LT.SPHENOID WING 3X3 Headache/vomiting III -2 GRADE 2 1 Improved 4
8 THANGAM 23/F 18738 24/03/11 LT.TENTORIAL 4X3 Headache/vomiting II -1 GRADE 2 1 pseudomeningocele 4
9 GOMATHY 45/F 27419 02/05/11 RT.TENTORIAL 3X3 Headache/vomiting II -1 GRADE 2 1 Improved 4
10 SUDHAKAR 31/M 29309 10/05/11 LT.CONVEXITY 5X4 Headache/Seizures II 2 GRADE 1 1 Improved 4
11 KANNAN 27/M 31932 21/05/11 RT.PARASAGITTAL 5X5 Headache/vomiting II 1 GRADE 2 1 Improved 4
12 SHANTHI 18/F 39651 16/06/11 LT.PARIETAL COMVEXITY 5X5 Headache/Seizures II 2 GRADE 1 1 Improved 4
13 BALAMMAL 40/F 38067 16/06/11 RT.PETROCLIVAL 4X3 Headache/vomiting II 0 GRADE 2 1 Improved 4
14 NALLAMMAL 55/F 45177 19/07/11 OLFACTORY GROOVE 3X2 Headache/papilledema II 1 GRADE 2 1 Improved 4
15 YESUNAYAGI 55/F 57078 07/09/11 LT. TEMPORAL 3X3 Headache/vomiting III -1 GRADE 1 2 behavioural changes 3
16 MURUGAN 40/M 57140 09/09/11 LT.SPHENOID WING 4X4 Headache/vomiting II 1 GRADE 2 1 Improved 4
17 RANJITHAM 52/F 58255 13/09/11 LT.FRONTOPARIETAL 3X3 Headache/Seizures II 1 GRADE 1 1 Improved 4
18 JEYARANI 65/F 72296 27/09/11 RT.PARIETAL CONVEXITY 5X5 Headache/Seizures III 0 GRADE 1 1 Improved 4
19 JANAKI 40/F 83922 17/11/11 LT.PARAFALCINE 4X3 Headache/vomiting II 0 GRADE 2 1 Rt. Hemiparesis 4
20 AZHAGI 40/F 76817 30/11/11 RT.TENTORIAL 4x4 Headache/Papilledema III -2 GRADE 1 1 Pseudomeningocele 2
21 PETCHIAMMAL 36/F 86988 01/12/11 LT.CONVEXITY 5X4 Headache/Seizures II 2 GRADE 1 1 Improved 4
22 VELLAYAMMAL 45/F 81356 13/12/11 RT.FRONTAL CONVEXITY 5x4 Headache/incontinence III 1 GRADE 1 1 Improved 4
 
 
 
MASTER CHART-CLASS Algorithm 
 
 
23 MARIAMMAL 42/F 06456 24/01/12 RT. FRONTAL CONVEXITY 4x3 Headache/Blurred vision III 0 GRADE 1 1 Improved 4
24 ANANDHI 28/F 09265 07/02/12 RT.ANT.PARASAGITTAL 5x4 Headache/Blurred vision III 2 GRADE 1 1 Improved 4
25 ADAIKKALAM 45/M 26208 16/04/12 RT.FRONTAL SUBFALCINE 3x4 Headache/Papilledema III 1 GRADE 3 1 Improved 4
26 SHANMUGHAM 40/M 35905 22/05/12 SUPRASELLAR 3x3 Bil.dim.vision III -2 GRADE 3 1 Visual defect/behavioural def 2
27 DEVI 47/F 45723 27/06/12 LT.FRONTAL PARASAGITTAL 4x3 Behaviour disturbances III 0 GRADE 3 1 Behavioual/hemiparesis 1
28 VELU 57/M 49474 13/07/12 RT.SPHENOID WING 3x2 Bil.dim.vision/giddiness III 0 GRADE 2 1 Improved 4
29 IRULAYEE 60/F 82993 27/07/12 LT.CP ANGLE 4x4 Headache/vomiting III 1 GRADE 2 1 Pseudomeningocele 1
30 NABISATH ISIRIYA 45/F 56039 09/08/12 RT.SPHENOID RIDGE 5x5 Headache/vomiting III 2 GRADE 1 1 Improved 4
31 ARUKKANI 75/F 60775 29/08/12 RT.BASIFRONTAL 3x3 Headache/vomiting III -3 GRADE 2 1 Improved 4
32 MEENA 32/F 62465 04/09/12 LT.PARASAGITTAL 3x2 Headache/vomiting II 0 GRADE 2 2 Improved 4
33 RAJENDRAN 52/M 64260 11/09/12 LT.LATERAL SPHENOID 5x4 Headache II 1 GRADE 2 1 Improved 4
34 THILAGAVATHY 37/F 65084 14/09/12 RT.TENTORIAL 5x4 Headache II 2 GRADE 2 1 Improved 4
35 BALASUBRAMANIAM 30/M 65720 28/09/12 LT. FRONTAL CONVEXITY 5x3 Headache/Diplopia III 1 GRADE 1 1 Improved 4
36 PALANIAMMAL 45/F 69983 03/10/12 SUPRASELLAR 3x2 Bil.Optic Atrophy II -1 GRADE 4 1 Visual deterioration 2
37 MUTHUKRISHNAVENI 18/F 74694 20/10/12 RT MID1/3 PARASAGITTAL 5x4 Headache/vomiting II 1 GRADE 2 1 Improved 4
38 MUTHUMEENA 37/F 69789 03/11/12 LT.CP ANGLE 4x4 Headache/vomiting II 0 GRADE 1 1 Improved 4
39 JOTHI 35/F 80214 05/11/12 LT. TENTORIAL 5x4 Headache/Loss of vision III 1 GRADE 1 1 pseudomeningocele/CSF leak 1
40 SHANTHI MURUGAN 30/F 89115 16/11/12 RT FRONTAL CONVEXITY 4x4 Seizures II 2 GRADE 1 1 Improved 4
41 PONMOZHI 40/F 97664 27/12/12 RT.CLINOIDAL 3x3 Headache/Blurred vision II -1 GRADE 3 1 Improved 5
42 GANESAN 55/M 96810 24/12/12 LT.MID 3RD PARASAGITTAL 5x4 Headache/vomiting II 1 GRADE 2 1 Improved 4
43 LAKSHMI 48/F 00597 03/01/13 INTRAVENTRICULAR 5x5 Headache/vomiting II 1 GRADE 3 1 DVT 1
44 RAJALAKSHMI 45/F 4500 10/01/13 OLFACTORY GROOVE 3x3 Anosmia/behavioural change I 1 GRADE 2 1 Improved 5
45 MEENA 35/F 5436 22/01/13 FALX MENINGIOMA 11x7 Seizures/Rt.hemiparesis II 2 GRADE 2 1 Aphasia/Rt.hemiplegia 4
46 NAGAMMAL 45/F 7737 19/01/13 LT.PARASAGITTAL 5x5 Seizures/rt.hemiparesis II 2 GRADE 2 1 hemiparesis 3
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